Welcome to our dedicated page for Nasdaq news (Ticker: NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.
Nasdaq Inc (NDAQ) drives innovation in global capital markets through its electronic trading platforms, market data services, and regulatory technology solutions. This dedicated news hub provides investors and professionals with direct access to official corporate announcements and market-moving developments.
Our curated collection simplifies tracking Nasdaq's strategic initiatives across its core business segments. Users will find timely updates on quarterly earnings, technology partnerships, regulatory compliance solutions, and market infrastructure enhancements. Each release maintains the original corporate messaging for accuracy.
Bookmark this page to monitor Nasdaq's evolving role in financial technology ecosystems, from AI-driven analytics to sustainable investing infrastructure. The resource serves as a primary channel for understanding how Nasdaq's innovations impact market transparency and operational efficiency worldwide.
Nasdaq has announced the delisting of common stocks for Centric Brands Inc. and Akorn, Inc. due to suspension of trading. Centric Brands was suspended on May 28, 2020, while Akorn's trading was suspended on June 1, 2020. Additionally, the warrants of Scienjoy Holding Corporation expiring on February 4, 2025 are also being delisted, having been suspended on June 2, 2020. A Form 25 will be filed with the Securities and Exchange Commission to finalize the delisting process, effective ten days post-filing.
Nasdaq (NDAQ) has announced a minority investment in UK-based financial crime investigation automation company Caspian. This partnership aims to enhance Caspian's automated anti-money laundering solutions and accelerate its product expansion. Nasdaq Ventures seeks to invest in technology disruptors that improve market transparency. Caspian's machine learning technologies promise increased productivity and cost savings for compliance teams in banks. The terms of the investment remain undisclosed, but the collaboration is expected to bolster both companies' capabilities in combating financial crime.
The Nasdaq Stock Market announced the delisting of Akazoo S.A.'s ordinary shares and warrant, effective ten days after filing a Form 25 with the SEC. The shares were suspended from trading on May 27, 2020, and have not traded since. Investors should refer to public filings for more information regarding the basis for the delisting and the status of the company's securities on other venues.
Nasdaq (NDAQ) announced its monthly trading volumes for May 2020, providing details on trading activity during the month. This information can be accessed through their investor relations website. The report highlights Nasdaq's ongoing efforts to keep stakeholders informed about trading metrics and market activities.
The Nasdaq Stock Market (NDAQ) has announced that trading in CNS Pharmaceuticals Inc. (CNSP) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. This follows a trading halt initiated on May 4, 2020, at 9:25:06 Eastern Time. The resumption of trading is significant for investors and reflects the ongoing activities of CNS Pharmaceuticals. For more details, stakeholders can look under the company's symbol on the Nasdaq website.
The Nasdaq Stock Market (Nasdaq: NDAQ) has announced that trading of Moleculin Biotech, Inc. (Nasdaq: MBRX) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. The trading was halted on May 4, 2020, at 9:25:06 a.m. Eastern Time. This resumption signifies the end of the trading disruption for MBRX stocks, allowing investors to re-engage with the market.
On May 26, 2020, Nasdaq CEO Adena Friedman announced her participation in two upcoming events. The first, Bernstein’s 36th Annual Strategic Decisions Conference, will take place on May 28, 2020, at 10:00 AM ET. The second event is the Piper Sandler Global Exchange & FinTech Conference, scheduled for June 4, 2020, also at 10:00 AM ET. Both presentations will be available via webcast on Nasdaq's Investor Relations website.
Nasdaq announced that trading in Luckin Coffee Inc. (NDAQ: LK) will resume on May 20, 2020, at 7:00 a.m. Eastern Time. The stock was halted on April 7, 2020, at 9:15:25 Eastern Time due to regulatory issues. This resumption follows the company's efforts to address compliance matters. For further details, investors can access information under the company’s symbol using InfoQuotes on the Nasdaq website.
The Nasdaq Stock Market (NDAQ) announced that the trading halt on CNS Pharmaceuticals Inc. (CNSP) has been switched to an "additional information requested" status. This trading halt began on May 4, 2020, at 9:25:06 Eastern Time, with a last sale price of $2.76. Trading will remain suspended until CNS Pharmaceuticals Inc. provides the required information to Nasdaq.
For further updates, stakeholders are advised to check the Nasdaq website or directly contact the company.
The Nasdaq Stock Market (NDAQ) announced on May 18, 2020, that trading in Moleculin Biotech Inc. (MBRX) has been halted since May 4, due to a request for additional information from the company. The last sale price before the halt was $1.07. Trading will remain suspended until Moleculin Biotech provides the required information to Nasdaq.
FAQ
What is the current stock price of Nasdaq (NDAQ)?
What is the market cap of Nasdaq (NDAQ)?
